Softwr

AI · head to head

LatchBio vs Rev

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Full reviewWebsite
Rev logo

Rev

AI

Human and AI transcription, captions and subtitles priced per minute

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only Rev has a free tier, so it costs nothing to try first.
  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Rev human transcription at 1.99 US dollars a minute means roughly 120 dollars an hour of audio, so a long-form interview series costs more in transcription than most teams assume before they run the arithmetic.
  • They diverge on capability: LatchBio covers Agent driven analysis, Rev covers Human transcription.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Rev actually diverge.

Attributes where LatchBio and Rev differ
AttributeLatchBioRev
Starting priceOn requestFree
Pricing modelquotePer minute for human work, per seat per month for AI
Free tierNoYes
PlatformsWebWeb, iOS, Android, API

Identical on both: user rating (Not yet rated), category (AI).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Rev

  • Human transcription
  • AI transcription
  • Captions and subtitles
  • Legal transcripts
  • File analysis
  • Clio integration
  • Rev API
  • Speaker identification

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Rev
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Rev
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Rev
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Rev

Rev

  • A law firm that needs a deposition transcript in a court-acceptable page format with a fixed turnaround and a published per-page price it can bill to a matter.not LatchBio
  • A documentary or podcast producer costing a project in advance, because human transcription at a published per-minute rate makes the transcription line item a known number.not LatchBio
  • A broadcaster needing compliant human captions rather than machine captions, where accuracy is a regulatory requirement and not a convenience.not LatchBio
  • A team with high AI volume and occasional high-stakes files, using the subscription for the bulk and paying the discounted human rate only where accuracy matters.not LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Rev

  • Human transcription at 1.99 US dollars a minute means roughly 120 dollars an hour of audio, so a long-form interview series costs more in transcription than most teams assume before they run the arithmetic.
  • AI minutes are allocated per seat per month and do not roll over, so bursty workloads, which is how most media production actually behaves, waste allowance in quiet months and run out in busy ones.
  • The product direction has moved towards legal and investigative use, so a newsroom or media buyer is choosing a tool whose roadmap priority sits elsewhere.
  • Foreign-language subtitles are priced from 6.49 to 15.99 US dollars per minute, an order of magnitude above transcription, which makes multi-language localisation of any volume of video expensive enough to change the plan.
  • Human turnaround is stated in hours rather than guaranteed contractually on the published plans, so a hard broadcast or filing deadline needs an agreement beyond the standard terms.

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Rev

Free
  • FreeFree
    • 45 AI transcription and caption minutes per month
    • Up to 5 files analysed
    • No human transcription included
  • Essentials$25.49/month
    • 5,000 AI minutes per seat per month
    • Up to 3 seats
    • 10 per cent discount on human transcription, captions and subtitles
  • Pro$47.99/month
    • 10,000 AI minutes per seat per month
    • Up to 5 seats
    • 15 per cent discount on human work
  • Unlimited$undefined/month
    • Unlimited AI minutes
    • Up to 500 files analysed at once
    • Dedicated account specialist

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose Rev if

  • You need human transcription.
  • You want to start without paying.
  • You work on Web, iOS, Android, API.
  • You also want ai transcription.
Rev review

Questions people ask

Is LatchBio or Rev better?
Neither clearly leads. LatchBio starts at On request and Rev at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Rev?
Rev has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for Rev.
Does LatchBio or Rev run on more platforms?
LatchBio runs on Web. Rev runs on Web, iOS, Android, API.
Can I use Rev for free?
Yes. Rev has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Rev is typically brought in for.
What can LatchBio do that Rev cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. Rev covers Human transcription, AI transcription, Captions and subtitles, Legal transcripts.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Rev: How much is human transcription?

1.99 US dollars per minute with a stated accuracy target above 99 per cent, typically returned within 12 hours. Subscribers get 10 to 15 per cent off.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Rev: Is there a free tier?

Yes, 45 AI minutes per month and up to 5 files analysed, with no human transcription included.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

Rev: Do unused AI minutes roll over?

No. The allowance is per seat per month and resets, which penalises irregular workloads.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Rev: Can it do subtitles in other languages?

Yes, across seventeen languages, priced from 6.49 to 15.99 US dollars per minute, considerably more than transcription.

Rev: Is Rev still a good choice for newsrooms?

It works, but the subscription tiers are now positioned around legal and investigative workflows, so a newsroom should compare it against a tool built specifically for journalism.

Share

Related pages

More on LatchBio

More on Rev

Keep looking

Other head to heads